Providence, RI3 Active Studies

Ankylosing Spondylitis Clinical Trials in Providence, RI

Find 3 actively recruiting ankylosing spondylitis clinical trials in Providence, RI. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
7,338
Enrolling

Recruiting Ankylosing Spondylitis Studies in Providence

About Ankylosing Spondylitis Clinical Trials in Providence

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 3 ankylosing spondylitis clinical trials recruiting participants in Providence, RI. These studies are seeking a combined 7,338 participants. Research is being sponsored by JHSPH Center for Clinical Trials, Washington University School of Medicine, Brown University. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Providence — FAQ

Are there ankylosing spondylitis clinical trials in Providence?

Yes, there are 3 ankylosing spondylitis clinical trials currently recruiting in Providence, RI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Providence?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Providence research site will contact you about next steps.

Are clinical trials in Providence free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Providence studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 3 active trials in Providence are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated September 4, 2026 from ClinicalTrials.gov